The expanding demand for precise immunological investigation and therapeutic creation has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using diverse expression methods, including prokaryotic hosts, animal cell lines, and baculov